Biotoxtech, “Rumor about purchasing Celltrion’s stocks is groundless information”
Regarding the Korea Exchange’s request for an inquiry notice on the 17th, Biotoxtech announced on the 18th “We have no important information to particularly notice for the recent significant change in the market condition(sudden increase of stock price).”
Moreover, the company said “A rumor from...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
